University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Melatonin 2mg M/R tablets (Circadin®)

REM sleep behaviour disorder and circadian rhythm sleep-wake disorder in adults

Status: Amber Melatonin 3mg tablets

REM sleep behaviour disorder and circadian rhythm sleep-wake disorder in adults

Status: Red Melatonin capsules

Unlicensed

Status: Red Melphalan injection

For hospital use only

Status: Amber Memantine tablets

Dementia drugs ESCA

Status: Green Meningiococcal A, C W135, and Y conjugate vaccine (Menveo®)

For use in patients visiting Saudi Arabia for Hajj and other high risk destinations. Likely to be more long lasting than the alternative polysaccharide vaccine. Supported with PGD.

Status: Green Meningiococcal group C conjugate vaccine (Menjugate Kit®, Neis Vac-C®)

Supported with PGD

Status: Green Menthol 1% in aqueous cream

Dermacool

Status: Red Mepacrine Hydrochloride

Unlicensed special

Status: Red Meptazinol (Meptid®)

HGS only

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top